The following tables present details of stock-based compensation, acquisition-related costs and restructuring expense included in each functional line item in the condensed consolidated statements of operations above:

		Three Months Ended October 31,								Nine Months Ended October 31,
			2024				2023				2024				2023
		(unaudited, in thousands)
Stock-based compensation:
Cost of revenue		$	899			$	868			$	2,339			$	2,694
Research and development			18,637				17,898				54,653				54,809
Selling, general and administrative			7,311				8,643				23,503				25,293
Total stock-based compensation		$	26,847			$	27,409			$	80,495			$	82,796

« Previous Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8  Next Page »